US 10092656
Protease inhibitors having enhanced features
granted A61KA61K31/4402A61K31/4433
Quick answer
US patent 10092656 (Protease inhibitors having enhanced features) held by Nektar Therapeutics expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/4402, A61K31/4433, A61K31/635, A61K38/05